Skip to main content
Erschienen in: Pathology & Oncology Research 1/2019

03.11.2017 | Original Article

A Potential Role for Green Tea as a Radiation Sensitizer for Prostate Cancer

verfasst von: Andrew C. Schroeder, Huaping Xiao, Ziwen Zhu, Qing Li, Qian Bai, Mark R. Wakefield, Jeffrey D. Mann, Yujiang Fang

Erschienen in: Pathology & Oncology Research | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Prostate cancer (PCa) is the most common non-cutaneous cancer in the United States. There is currently a lack of safe and effective radiosensitizers that can enhance the effectiveness of radiation treatment (RT) for Pca. Clonogenic assay, PCNA staining, Quick Cell Proliferation assay, TUNEL staining and caspase-3 activity assay were used to assess proliferation and apoptosis in DU145 Pca cells. RT-PCR/IHC were used to investigate the mechanisms. We found that the percentage of colonies, PCNA staining intensity, and the optical density value of DU145 cells were decreased (RT/GT vs. RT). TUNEL + cells and the relative caspase-3 activity were increased (RT/GT vs. RT). Compared to RT, the anti-proliferative effect of RT/GT correlated with increased expression of the anti-proliferative molecule p16. Compared to RT, the pro-apoptotic effect of RT/GT correlated with decreased expression of the anti-apoptotic molecule Bcl-2. GT enhances RT sensitivity of DU145 by inhibiting proliferation and promoting apoptosis.
Literatur
2.
Zurück zum Zitat Bernard W, Christopher P (2014) World cancer report 2014. International Agency for Research on Cancer. World Health Organization, Lyon, France Bernard W, Christopher P (2014) World cancer report 2014. International Agency for Research on Cancer. World Health Organization, Lyon, France
3.
Zurück zum Zitat Zhang S, Shan L, Li Q, Wang X, Li S, Zhang Y, Fu J, Liu X, Li H, Zhang W (2014) Systematic analysis of the multiple bioactivities of green tea through a network pharmacology approach. Evid Based Complement Alternat Med 2014:512081. https://doi.org/10.1155/2014/512081 Zhang S, Shan L, Li Q, Wang X, Li S, Zhang Y, Fu J, Liu X, Li H, Zhang W (2014) Systematic analysis of the multiple bioactivities of green tea through a network pharmacology approach. Evid Based Complement Alternat Med 2014:512081. https://​doi.​org/​10.​1155/​2014/​512081
4.
Zurück zum Zitat Fang Y, DeMarco VG, Nicholl MB (2012) Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 103(6):1090–1098CrossRefPubMed Fang Y, DeMarco VG, Nicholl MB (2012) Resveratrol enhances radiation sensitivity in prostate cancer by inhibiting cell proliferation and promoting cell senescence and apoptosis. Cancer Sci 103(6):1090–1098CrossRefPubMed
6.
Zurück zum Zitat Liang X, Gao J, Sun X, Zhu L, Jia Y, Gu Y, Han C, Zhang X, Hou S (2013) [Tea polyphenols inhibits the proliferation of prostate cancer DU145 cells]. Zhonghua nan ke xue=. Natl J Androl 19(6):495–500 Liang X, Gao J, Sun X, Zhu L, Jia Y, Gu Y, Han C, Zhang X, Hou S (2013) [Tea polyphenols inhibits the proliferation of prostate cancer DU145 cells]. Zhonghua nan ke xue=. Natl J Androl 19(6):495–500
7.
Zurück zum Zitat Kwak TW, Park SB, Kim H-J, Jeong Y-I, Kang DH (2017) Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. OncoTargets Ther 10:137CrossRef Kwak TW, Park SB, Kim H-J, Jeong Y-I, Kang DH (2017) Anticancer activities of epigallocatechin-3-gallate against cholangiocarcinoma cells. OncoTargets Ther 10:137CrossRef
8.
Zurück zum Zitat Naponelli V, Ramazzina I, Lenzi C, Bettuzzi S, Rizzi F (2017) Green tea Catechins for prostate cancer prevention: present achievements and future challenges. Antioxidants 6(2):26CrossRefPubMedCentral Naponelli V, Ramazzina I, Lenzi C, Bettuzzi S, Rizzi F (2017) Green tea Catechins for prostate cancer prevention: present achievements and future challenges. Antioxidants 6(2):26CrossRefPubMedCentral
9.
Zurück zum Zitat Oya Y, Mondal A, Rawangkan A, Umsumarng S, Iida K, Watanabe T, Kanno M, Suzuki K, Li Z, Kagechika H, Shudo K, Fujiki H, Suganuma M (2017) Down-regulation of histone deacetylase 4, −5 and −6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin. J Nutr Biochem 42:7–16. https://doi.org/10.1016/j.jnutbio.2016.12.015 CrossRefPubMed Oya Y, Mondal A, Rawangkan A, Umsumarng S, Iida K, Watanabe T, Kanno M, Suzuki K, Li Z, Kagechika H, Shudo K, Fujiki H, Suganuma M (2017) Down-regulation of histone deacetylase 4, −5 and −6 as a mechanism of synergistic enhancement of apoptosis in human lung cancer cells treated with the combination of a synthetic retinoid, Am80 and green tea catechin. J Nutr Biochem 42:7–16. https://​doi.​org/​10.​1016/​j.​jnutbio.​2016.​12.​015 CrossRefPubMed
10.
Zurück zum Zitat Tsai Y-J, Chen B-H (2016) Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3. Int J Nanomedicine 11:1907CrossRefPubMedPubMedCentral Tsai Y-J, Chen B-H (2016) Preparation of catechin extracts and nanoemulsions from green tea leaf waste and their inhibition effect on prostate cancer cell PC-3. Int J Nanomedicine 11:1907CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Henning SM, Aronson W, Niu Y, Conde F, Lee NH, Seeram NP, Lee R-P, Lu J, Harris DM, Moro A (2006) Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr 136(7):1839–1843CrossRefPubMed Henning SM, Aronson W, Niu Y, Conde F, Lee NH, Seeram NP, Lee R-P, Lu J, Harris DM, Moro A (2006) Tea polyphenols and theaflavins are present in prostate tissue of humans and mice after green and black tea consumption. J Nutr 136(7):1839–1843CrossRefPubMed
12.
Zurück zum Zitat Fang Y, Bradley MJ, Cook KM, Herrick EJ, Nicholl MB (2013) A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res 183(2):645–653CrossRefPubMed Fang Y, Bradley MJ, Cook KM, Herrick EJ, Nicholl MB (2013) A potential role for resveratrol as a radiation sensitizer for melanoma treatment. J Surg Res 183(2):645–653CrossRefPubMed
13.
Zurück zum Zitat Fang Y, Braley-Mullen H (2008) Cultured murine thyroid epithelial cells expressing transgenic Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein are protected from Fas-mediated apoptosis. Endocrinology 149(7):3321–3329CrossRefPubMedPubMedCentral Fang Y, Braley-Mullen H (2008) Cultured murine thyroid epithelial cells expressing transgenic Fas-associated death domain-like interleukin-1β converting enzyme inhibitory protein are protected from Fas-mediated apoptosis. Endocrinology 149(7):3321–3329CrossRefPubMedPubMedCentral
14.
Zurück zum Zitat Fang Y, Sharp GC, Braley-Mullen H (2008) Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 172(6):1591–1602CrossRefPubMedPubMedCentral Fang Y, Sharp GC, Braley-Mullen H (2008) Interleukin-10 promotes resolution of granulomatous experimental autoimmune thyroiditis. Am J Pathol 172(6):1591–1602CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Fang Y, Wei Y, DeMarco V, Chen K, Sharp GC, Braley-Mullen H (2007) Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice. Am J Pathol 170(3):875–887CrossRefPubMedPubMedCentral Fang Y, Wei Y, DeMarco V, Chen K, Sharp GC, Braley-Mullen H (2007) Murine FLIP transgene expressed on thyroid epithelial cells promotes resolution of granulomatous experimental autoimmune thyroiditis in DBA/1 mice. Am J Pathol 170(3):875–887CrossRefPubMedPubMedCentral
16.
Zurück zum Zitat Fang Y, Moore BJ, Bai Q, Cook KM, Herrick EJ, Nicholl MB (2013) Hydrogen peroxide enhances radiation-induced apoptosis and inhibition of melanoma cell proliferation. Anticancer Res 33(5):1799–1807PubMed Fang Y, Moore BJ, Bai Q, Cook KM, Herrick EJ, Nicholl MB (2013) Hydrogen peroxide enhances radiation-induced apoptosis and inhibition of melanoma cell proliferation. Anticancer Res 33(5):1799–1807PubMed
17.
Zurück zum Zitat Fang Y, Herrick EJ, Nicholl MB (2012) A possible role for perforin and Granzyme B in resveratrol-enhanced Radiosensitivity of prostate cancer. J Androl 33(4):752–760CrossRefPubMed Fang Y, Herrick EJ, Nicholl MB (2012) A possible role for perforin and Granzyme B in resveratrol-enhanced Radiosensitivity of prostate cancer. J Androl 33(4):752–760CrossRefPubMed
18.
Zurück zum Zitat Fang Y, Sharp GC, Yagita H, Braley-Mullen H (2008) A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J Pathol 216(4):505–513CrossRefPubMedPubMedCentral Fang Y, Sharp GC, Yagita H, Braley-Mullen H (2008) A critical role for TRAIL in resolution of granulomatous experimental autoimmune thyroiditis. J Pathol 216(4):505–513CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Johnson D, Walker C (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39(1):295–312CrossRef Johnson D, Walker C (1999) Cyclins and cell cycle checkpoints. Annu Rev Pharmacol Toxicol 39(1):295–312CrossRef
21.
Zurück zum Zitat Nobori T (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Trends Genet 10(7):228CrossRef Nobori T (1994) Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Trends Genet 10(7):228CrossRef
22.
Zurück zum Zitat Helgadottir H, Höiom V, Jönsson G, Tuominen R, Ingvar C, Borg Å, Olsson H, Hansson J (2014) High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet 51(8):545–552CrossRefPubMedPubMedCentral Helgadottir H, Höiom V, Jönsson G, Tuominen R, Ingvar C, Borg Å, Olsson H, Hansson J (2014) High risk of tobacco-related cancers in CDKN2A mutation-positive melanoma families. J Med Genet 51(8):545–552CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8(1):27–32CrossRefPubMed Caldas C, Hahn SA, da Costa LT, Redston MS, Schutte M, Seymour AB, Weinstein CL, Hruban RH, Yeo CJ, Kern SE (1994) Frequent somatic mutations and homozygous deletions of the p16 (MTS1) gene in pancreatic adenocarcinoma. Nat Genet 8(1):27–32CrossRefPubMed
24.
Zurück zum Zitat Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270(5239):1189–1192CrossRefPubMed Griffith TS, Brunner T, Fletcher SM, Green DR, Ferguson TA (1995) Fas ligand-induced apoptosis as a mechanism of immune privilege. Science 270(5239):1189–1192CrossRefPubMed
25.
Zurück zum Zitat Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267(5203):1456CrossRef Thompson CB (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267(5203):1456CrossRef
27.
Zurück zum Zitat Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Pawłowski K, Godzik A, Reed JC (2000) BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci 97(6):2597–2602CrossRefPubMed Zhang H, Xu Q, Krajewski S, Krajewska M, Xie Z, Fuess S, Kitada S, Pawłowski K, Godzik A, Reed JC (2000) BAR: an apoptosis regulator at the intersection of caspases and Bcl-2 family proteins. Proc Natl Acad Sci 97(6):2597–2602CrossRefPubMed
28.
29.
Zurück zum Zitat Khanna K, Wie T, Song Q, Burrows S, Moss D, Krajewski S, Reed J, Lavin M (1996) Expression of p53, bcl-2, bax, bcl-x2 and c-myc in radiation-induced apoptosis in Burkitt's lymphoma cells. Cell Death Differ 3(3):315–322PubMed Khanna K, Wie T, Song Q, Burrows S, Moss D, Krajewski S, Reed J, Lavin M (1996) Expression of p53, bcl-2, bax, bcl-x2 and c-myc in radiation-induced apoptosis in Burkitt's lymphoma cells. Cell Death Differ 3(3):315–322PubMed
30.
Zurück zum Zitat Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC (1996) Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 148(5):1567PubMedPubMedCentral Krajewska M, Krajewski S, Epstein JI, Shabaik A, Sauvageot J, Song K, Kitada S, Reed JC (1996) Immunohistochemical analysis of bcl-2, bax, bcl-X, and mcl-1 expression in prostate cancers. Am J Pathol 148(5):1567PubMedPubMedCentral
31.
Zurück zum Zitat Tron V, Krajewski S, Klein-Parker H, Li G, Ho V, Reed J (1995) Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am J Pathol 146(3):643PubMedPubMedCentral Tron V, Krajewski S, Klein-Parker H, Li G, Ho V, Reed J (1995) Immunohistochemical analysis of Bcl-2 protein regulation in cutaneous melanoma. Am J Pathol 146(3):643PubMedPubMedCentral
32.
Zurück zum Zitat Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228(4706):1440–1443CrossRefPubMed Tsujimoto Y, Cossman J, Jaffe E, Croce CM (1985) Involvement of the bcl-2 gene in human follicular lymphoma. Science 228(4706):1440–1443CrossRefPubMed
33.
Zurück zum Zitat Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C (2006) Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 12(19):5726–5732CrossRefPubMed Yip KW, Shi W, Pintilie M, Martin JD, Mocanu JD, Wong D, MacMillan C, Gullane P, O'Sullivan B, Bastianutto C (2006) Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer. Clin Cancer Res 12(19):5726–5732CrossRefPubMed
34.
Zurück zum Zitat Zhu Z, Davidson KT, Brittingham A, Wakefield MR, Bai Q, Xiao H, Fang Y (2016) Trichomonas vaginalis: a possible foe to prostate cancer. Med Oncol 33(10):115CrossRefPubMed Zhu Z, Davidson KT, Brittingham A, Wakefield MR, Bai Q, Xiao H, Fang Y (2016) Trichomonas vaginalis: a possible foe to prostate cancer. Med Oncol 33(10):115CrossRefPubMed
Metadaten
Titel
A Potential Role for Green Tea as a Radiation Sensitizer for Prostate Cancer
verfasst von
Andrew C. Schroeder
Huaping Xiao
Ziwen Zhu
Qing Li
Qian Bai
Mark R. Wakefield
Jeffrey D. Mann
Yujiang Fang
Publikationsdatum
03.11.2017
Verlag
Springer Netherlands
Erschienen in
Pathology & Oncology Research / Ausgabe 1/2019
Print ISSN: 1219-4956
Elektronische ISSN: 1532-2807
DOI
https://doi.org/10.1007/s12253-017-0358-4

Weitere Artikel der Ausgabe 1/2019

Pathology & Oncology Research 1/2019 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.